About their pathological roles, particularly in cancer diseases (Table 1), PARP6 contributes to the maintenance of centrosome integrity by MARylating the checkpoint kinase and promoting the breast cancer growth [78], while PARP15 is overexpressed in B-aggressive lymphoma [79] and acute myeloid leukemia [80]. The gene discussed is PARP6; the disease is breast carcinoma.